What medications are recommended to help with falling asleep?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: October 22, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Medications for Falling Asleep

For patients with difficulty falling asleep, short-intermediate acting benzodiazepine receptor agonists (BzRAs) or ramelteon are recommended as first-line pharmacological treatments. 1

First-Line Pharmacological Options

  • Zolpidem (10mg, 5mg in elderly) is effective for both sleep onset and sleep maintenance insomnia 1
  • Zaleplon (10mg) is specifically recommended for sleep onset insomnia 1
  • Eszopiclone (2-3mg) is effective for both sleep onset and sleep maintenance insomnia 1
  • Ramelteon (8mg) is recommended specifically for sleep onset insomnia and works on melatonin receptors without risk of tolerance 1, 2

Second-Line Options

  • Temazepam (15mg) can be used for both sleep onset and sleep maintenance insomnia when first-line agents are ineffective 1
  • Doxepin (3-6mg) is suggested primarily for sleep maintenance insomnia 1
  • Suvorexant (orexin receptor antagonist) is recommended for sleep maintenance issues 1, 2

Treatment Algorithm

  1. Begin with cognitive behavioral therapy for insomnia (CBT-I) as the initial treatment for all adults with chronic insomnia due to its superior long-term efficacy and minimal risk of adverse effects 1, 2
  2. If medication is necessary, start with short/intermediate-acting BzRAs (zolpidem, zaleplon, eszopiclone) or ramelteon 1
  3. For sleep onset difficulty specifically, consider zaleplon, ramelteon, or zolpidem 1
  4. If first-line agents fail, try alternative BzRAs or consider sedating antidepressants for patients with comorbid depression/anxiety 1

Special Considerations for Older Adults

  • Lower doses should be used in elderly patients (e.g., zolpidem 5mg instead of 10mg) 1, 3
  • Benzodiazepines should be avoided when possible in older adults due to increased risk of falls, cognitive impairment, and dependence 4, 3
  • Ramelteon has a minimal adverse effect profile, making it a valuable first-line option for older adults 3

Medications to Avoid

  • Over-the-counter antihistamines (e.g., diphenhydramine) are not recommended due to lack of efficacy data and safety concerns 1, 3
  • Trazodone is not recommended for sleep onset insomnia 1
  • Tiagabine (anticonvulsant) is not recommended for sleep onset or maintenance insomnia 1
  • Herbal supplements (e.g., valerian) and melatonin have insufficient evidence of efficacy 1
  • Older hypnotics including barbiturates and chloral hydrate are not recommended 1

Important Clinical Considerations

  • Short-term hypnotic treatment should be supplemented with behavioral and cognitive therapies 1, 5
  • Use medications for the shortest duration possible at the lowest effective dose 5, 6
  • Monitor patients regularly to assess effectiveness and side effects 1
  • Long-term use of benzodiazepines and non-benzodiazepine hypnotics can lead to tolerance and diminished efficacy 2, 7
  • Sleep hygiene education (regular exercise, daytime bright light exposure, comfortable sleep environment, avoiding heavy meals/alcohol/nicotine near bedtime) should be part of any insomnia treatment plan 4

Common Pitfalls to Avoid

  • Using sedating agents without considering their specific effects on sleep onset versus maintenance 1
  • Failing to consider drug interactions and contraindications 1
  • Continuing pharmacotherapy long-term without periodic reassessment 1, 2
  • Abrupt discontinuation of benzodiazepines or z-drugs, which can precipitate withdrawal symptoms 2
  • Focusing solely on pharmacological approaches without addressing behavioral components 2, 5

References

Guideline

Pharmacotherapy of Insomnia

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Managing Insomnia with Tolerance to Multiple Medications

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

Treatment of Chronic Insomnia in Adults.

American family physician, 2024

Research

Treatment options for insomnia.

American family physician, 2007

Research

Medications for the Treatment of Sleep Disorders: An Overview.

Primary care companion to the Journal of clinical psychiatry, 2001

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.